Eli Lilly and Company - Return On Equity

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in Percent.

The item "Return-On-Equity" stands at 102.26 percent as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.

As of the end of Eli Lilly and Company's third quarter, the item "Return On Equity" stands at 102.26 Percent. This represents an increase of 13.89 percentage points compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 37.10 percentage points compared to the value the year prior.
The 1 year change in percentage points is 37.10.
The 3 year change in percentage points is 36.90.

The Serie's long term average value is 66.99 percent. It's latest available value, on 09/30/2025, is 35.27 percentage points higher, compared to it's long term average value.
The Serie's change in percentage points from it's minimum value, on 09/30/2023, to it's latest available value, on 09/30/2025, is +57.04.
The Serie's change in percentage points from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0.